Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee

  1. Lin, Y.
  2. Qiu, L.
  3. Usmani, S.
  4. Joo, C.W.
  5. Costa, L.
  6. Derman, B.
  7. Du, J.
  8. Einsele, H.
  9. Fernandez de Larrea, C.
  10. Hajek, R.
  11. Ho, P.J.
  12. Kastritis, E.
  13. Martinez-Lopez, J.
  14. Mateos, M.-V.
  15. Mikhael, J.
  16. Moreau, P.
  17. Nagarajan, C.
  18. Nooka, A.
  19. O'Dwyer, M.
  20. Schjesvold, F.
  21. Sidana, S.
  22. van de Donk, N.W.
  23. Weisel, K.
  24. Zweegman, S.
  25. Raje, N.
  26. Otero, P.R.
  27. Anderson, L.D.
  28. Kumar, S.
  29. Martin, T.
  30. Show all authors +
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2024

Type: Review

DOI: 10.1016/S1470-2045(24)00094-9 GOOGLE SCHOLAR